Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Novomics logo — company profile

Novomics

Founded 2010 Korea South Korea South 6 employees Series C Total: $1.50B Health Care

General Information

Company Name Novomics
Founded Year 2010
Location Korea South Korea South +1
Employees 6
Industries Health Care
Funding Stage Series C
Social

Get notified when Novomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Novomics

Novomics, founded in 2010, is a pioneering company in the Health Care industry, based in South Korea. The company's primary focus lies in gene-based molecular diagnosis, with a relentless pursuit of becoming the leader in this field. Collaborating with researchers, clinical physicians, and pharmaceutical companies, Novomics is dedicated to enhancing the understanding of cancer gene analysis for the advancement of precision medicine. This focus ultimately aims to provide molecular diagnostic treatment for the standard care of cancer patients. In a significant milestone, Novomics secured a notable KRW1.00B Series C investment on 01 January 2017, with Stonebridge Ventures stepping in as the investor. This injection of funds is poised to fuel the company's ongoing quest to uncover new target genes and accumulate clinical experiences, ultimately contributing to the betterment of cancer patients' lives.

Taxonomy: molecular diagnosis, gene-based diagnosis, precision medicine, cancer treatment, clinical experiences, target genes, pharmaceutical companies, cancer gene analysis, standard care, NGS, precision medicine, clinical advancements, academic achievements, collaborative relationships

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 1
Investor
01 Jan 2017
Series B •••••• 1
Investor
01 Dec 2016
Pre Seed Round •••••• 1 •••• •••• 01 Dec 2013

Novomics Alternatives & Competitors

Novomics vs
xMD Diagnostics, Inc.
xMD Diagnostics, Inc. United States

Enabling precision diagnostics

Non Equity Assistance
2 employees
Biotechnology, Health Care
Novomics vs
Immuneel Therapeutics Pvt. Ltd.
Immuneel Therapeutics Pvt. Ltd. India

Accelerating access to Cell & Gene Therapies

Series A
73 employees
Health Care, Health and Wellness
Novomics vs
Xcoo
Xcoo Japan

Genomic Intelligence Based on Advanced Computing, Chrovis

14 employees

FAQ About Novomics

Novomics is always pursuing to become the best in the area of gene-based molecular diagnosis. We are continuously accumulating clinical experiences by excavating new target genes in association with researchers, clinical physicians and pharmaceutical companies for the realization of "For better life...
Novomics was founded in 2010.
Novomics is headquartered in Korea South.
Novomics operates in the following industries: Health Care.
Novomics has approximately 6 employees.
Novomics has completed 3 funding rounds, raising a total of $1.50B. The latest funding stage is Series C.
Top alternatives and competitors to Novomics include xMD Diagnostics, Inc., Immuneel Therapeutics Pvt. Ltd., Xcoo, Beijing Gene+ Technology, GeneCraft Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novomics and xMD Diagnostics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Novomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes